{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:26:50Z","timestamp":1786980410919,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00726-020-02914-4","type":"journal-article","created":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T12:02:22Z","timestamp":1605441742000},"page":"1559-1580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Synthetic analogues of memantine as neuroprotective and influenza viral inhibitors: in vitro and physicochemical studies"],"prefix":"10.1007","volume":"52","author":[{"given":"Aleksandra","family":"Tencheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana V.","family":"Volkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslav","family":"Chayrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavor","family":"Mitrev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"\u0160t\u00edcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2750-5813","authenticated-orcid":false,"given":"Ivanka","family":"Stankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German L.","family":"Perlovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,15]]},"reference":[{"key":"2914_CR1","unstructured":"ACD\/ChemSketch program. https:\/\/eduinf.waw.pl\/che\/inne\/prgchem\/pages\/chsk_eng.pdf"},{"issue":"3","key":"2914_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1192\/bjp.135.3.216","volume":"135","author":"R Adolfsson","year":"1979","unstructured":"Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135(3):216\u2013223. https:\/\/doi.org\/10.1192\/bjp.135.3.216","journal-title":"Br J Psychiatry"},{"key":"2914_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002745.pub4","author":"MG Alves Galv\u00e3o","year":"2014","unstructured":"Alves Galv\u00e3o MG, Rocha Crispino Santos MA, Alves da Cunha AJ (2014) Amantadine and rimantadine for influenza A in children and the elderly. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD002745.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2914_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","volume":"76","author":"R Anand","year":"2014","unstructured":"Anand R, Gill KD, Mahdi AA (2014) Therapeutics of Alzheimer\u2019s disease: past, present and future. Neuropharmacology 76:27\u201350. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.07.004","journal-title":"Neuropharmacology"},{"key":"2914_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejps.2015.05.008","volume":"76","author":"A Andr\u00e9s","year":"2015","unstructured":"Andr\u00e9s A, Ros\u00e9s M, R\u00e0fols C, Bosch E, Espinosa S, Segarra V, Huerta JM (2015) Setup and validation of shake-flask procedures for the determination of partition coefficients (log P) from low drug amounts. Eur J Pharm Sci 76:181\u2013191. https:\/\/doi.org\/10.1016\/j.ejps.2015.05.008","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"2914_CR6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1080\/02699050410001720130","volume":"18","author":"DB Arciniegas","year":"2004","unstructured":"Arciniegas DB, Frey KL, Anderson CA, Brousseau KM, Harris SN (2004) Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy. Brain Inj 18(12):1309\u20131318. https:\/\/doi.org\/10.1080\/02699050410001720130","journal-title":"Brain Inj"},{"issue":"9770","key":"2914_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer\u2019sdisease. Lancet 377(9770):1019\u20131031. https:\/\/doi.org\/10.1016\/S0140-6736(10)61349-9","journal-title":"Lancet"},{"key":"2914_CR8","first-page":"2169","volume":"27","author":"VA Borodin","year":"1982","unstructured":"Borodin VA, Kozlovsky EV, Vasilev VP (1982) Computer analysis of the results of calorimetric measurements in study on complex equilibriums in solutions. Russian J Inorganic Chem 27:2169\u20132172","journal-title":"Russian J Inorganic Chem"},{"key":"2914_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev-pharmtox-011613-135932","volume":"54","author":"K Chiang","year":"2014","unstructured":"Chiang K, Koo EH (2014) Emerging therapeutics for Alzheimer\u2019s disease. Annu Rev Pharmacol Toxicol 54:381\u2013405. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011613-135932","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3620","key":"2914_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.144.3620.862","volume":"144","author":"WL Davies","year":"1964","unstructured":"Davies WL, Grunert RR, Haff RF, Mcgahen JW, Neumayer EM, Paulshock M, Watts JC, Wood TR, Hermann EC, Hoffmann CE (1964) Antiviral activity of 1-adamantanamine (Amantadine). Science 144(3620):862\u2013863. https:\/\/doi.org\/10.1126\/science.144.3620.862","journal-title":"Science"},{"key":"2914_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejps.2015.03.019","volume":"73","author":"M Di Cagno","year":"2015","unstructured":"Di Cagno M, Bibi HA, Bauer-Brandl A (2015) New biomimetic barrier PermeapadTM for efficient investigation of passive permeability of drugs. Eur J Pharm Sci 73:29\u201334. https:\/\/doi.org\/10.1016\/j.ejps.2015.03.019","journal-title":"Eur J Pharm Sci"},{"key":"2914_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","volume":"82","author":"LY Di Marco","year":"2015","unstructured":"Di Marco LY, Venneri A, Farkas E, Evans PC, Marzo A, Frangi AF (2015) Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease\u2014a review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiol Dis 82:593\u2013606. https:\/\/doi.org\/10.1016\/j.nbd.2015.08.014","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2914_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2174\/1871527315666160321105039","volume":"15","author":"B Di Marco","year":"2016","unstructured":"Di Marco B, Bonaccorso CM, Aloisi E, Antoni S, Catania MV (2016) Neuro-inflammatory mechanisms in developmental disorders associated with intellectual disability and autism spectrum disorder: a neuro-immune perspective. CNS Neurol Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 15(4):448\u2013463. https:\/\/doi.org\/10.2174\/1871527315666160321105039","journal-title":"CNS Neurol Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"key":"2914_CR14","unstructured":"Di L, Kerns EH (2015) Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization. Academic press NY"},{"issue":"1","key":"2914_CR15","first-page":"7","volume":"51","author":"R Dingledine","year":"1999","unstructured":"Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51(1):7\u201362","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2914_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jalz.2006.10.004","volume":"3","author":"RS Doody","year":"2007","unstructured":"Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM (2007) Meta-analysis of six-month memantine trials in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 3(1):7\u201317. https:\/\/doi.org\/10.1016\/j.jalz.2006.10.004","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"18","key":"2914_CR17","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/cbic.200900321","volume":"10","author":"P Faller","year":"2009","unstructured":"Faller P (2009) Copper and zinc binding to amyloid-\u03b2: coordination, dynamics, aggregation. Reactivity Metal-Ion Trans ChemBioChem 10(18):2837\u20132845. https:\/\/doi.org\/10.1002\/cbic.200900321","journal-title":"Reactivity Metal-Ion Trans ChemBioChem"},{"issue":"5","key":"2914_CR18","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.pharep.2016.06.009","volume":"68","author":"M Gamdzyk","year":"2016","unstructured":"Gamdzyk M, Ziembowicz A, Bratek E, Salinska E (2016) Combining hypobaric hypoxia or hyperbaric oxygen postconditioning with memantine reduces neuroprotection in 7-day-old rat hypoxia-ischemia. Pharmacol Rep 68(5):1076\u20131083. https:\/\/doi.org\/10.1016\/j.pharep.2016.06.009","journal-title":"Pharmacol Rep"},{"issue":"3","key":"2914_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/jnr.21135","volume":"85","author":"ML Giuffrida","year":"2007","unstructured":"Giuffrida ML, Grasso G, Ruvo M, Pedone C, Saporito A, Marasco D, Pignataro B, Cascio C, Copani A, Rizzarelli E (2007) A\u03b2 (25\u201335) and its C-and\/or N-blocked derivatives: copper driven structural features and neurotoxicity. J Neurosci Res 85(3):623\u2013633. https:\/\/doi.org\/10.1002\/jnr.21135","journal-title":"J Neurosci Res"},{"issue":"1","key":"2914_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1749-6632.1991.tb00192.x","volume":"640","author":"WD Heiss","year":"1991","unstructured":"Heiss WD, Szelies B, Kessler J, Herholz K (1991) Abnormalities of energy metabolism in Alzheimer\u2019s disease studied with PET a. Ann N Y Acad Sci 640(1):65\u201371. https:\/\/doi.org\/10.1111\/j.1749-6632.1991.tb00192.x","journal-title":"Ann N Y Acad Sci"},{"key":"2914_CR21","first-page":"117","volume":"4","author":"T Higuchi","year":"1965","unstructured":"Higuchi T (1965) A phase solubility technique. Adv Anal Chem Instrum 4:117\u2013211","journal-title":"Adv Anal Chem Instrum"},{"issue":"6","key":"2914_CR22","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/jcb.22877","volume":"111","author":"J Hu","year":"2010","unstructured":"Hu J, Zhao TZ, Chu WH, Luo CX, Tang WH, Yi L, Feng H (2010) Protective effects of 20-hydroxyecdysone on CoCl2-induced cell injury in PC12 cells. J Cell Biochem 111(6):1512\u20131521. https:\/\/doi.org\/10.1002\/jcb.22877","journal-title":"J Cell Biochem"},{"issue":"14","key":"2914_CR23","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1212\/WNL.0b013e31824e8f0d","volume":"78","author":"G Hubsher","year":"2012","unstructured":"Hubsher G, Haider M, Okun MS (2012) Amantadine: the journey from fighting flu to treating Parkinson disease. Neurology 78(14):1096\u20131099. https:\/\/doi.org\/10.1212\/WNL.0b013e31824e8f0d","journal-title":"Neurology"},{"issue":"1","key":"2914_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","volume":"6","author":"JW Johnson","year":"2006","unstructured":"Johnson JW, Kotermanski SE (2006) Mechanism of action of memantine. Curr Opin Pharmacol 6(1):61\u201367. https:\/\/doi.org\/10.1016\/j.coph.2005.09.007","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"2914_CR25","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.neurobiolaging.2011.08.011","volume":"33","author":"JH Kim","year":"2012","unstructured":"Kim JH, Lee HW, Hwang J, Kim J, Lee MJ, Han HS, Lee WH, Suk K (2012) Microglia-inhibiting activity of Parkinson\u2019s disease drug amantadine. Neurobiol Aging 33(9):2145\u20132159. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.08.011","journal-title":"Neurobiol Aging"},{"issue":"15","key":"2914_CR26","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0040-4039(00)99616-3","volume":"30","author":"R Knorr","year":"1989","unstructured":"Knorr R, Trzeciak A, Bannwarth W, Gillessen D (1989) New coupling reagents in peptide chemistry. Tetrahedron Lett 30(15):1927\u20131930","journal-title":"Tetrahedron Lett"},{"key":"2914_CR27","first-page":"78","volume-title":"Ekstraktsiya v analize organicheskikh veshchestv. Extraction in the analysis of organic compounds","author":"IM Korenman","year":"1977","unstructured":"Korenman IM (1977) Ekstraktsiya v analize organicheskikh veshchestv. Extraction in the analysis of organic compounds. Moscow, Khimiya, pp 78\u201384"},{"key":"2914_CR28","first-page":"91","volume":"43","author":"J Kornhuber","year":"1994","unstructured":"Kornhuber J, Weller M, Schoppmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl 43:91\u2013104","journal-title":"J Neural Transm Suppl"},{"issue":"1","key":"2914_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/med.20248","volume":"33","author":"R Leon","year":"2013","unstructured":"Leon R, Garcia AG, Marco-Contelles J (2013) Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer\u2019s disease. Med Res Rev 33(1):139\u2013189. https:\/\/doi.org\/10.1002\/med.20248","journal-title":"Med Res Rev"},{"key":"2914_CR30","first-page":"38","volume":"4","author":"GD Liang","year":"2010","unstructured":"Liang GD, Zhang YW, Lin DE (2010) Synthesis of memantine derivatives. Chinese J Synthetic Chem 4:38","journal-title":"Chinese J Synthetic Chem"},{"issue":"2","key":"2914_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrd1958","volume":"5","author":"SA Lipton","year":"2006","unstructured":"Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discovery 5(2):160. https:\/\/doi.org\/10.1038\/nrd1958","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"2914_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1741-7015-10-105","volume":"10","author":"R Liu","year":"2012","unstructured":"Liu R, Wu CX, Zhou D, Yang F, Tian S, Zhang L, Zhang TT, Du GH (2012) Pinocembrin protects against \u03b2-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis. BMC medicine 10(1):105. https:\/\/doi.org\/10.1186\/1741-7015-10-105","journal-title":"BMC medicine"},{"key":"2914_CR33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.lfs.2017.10.041","volume":"193","author":"QS Liu","year":"2018","unstructured":"Liu QS, Jiang HL, Wang Y, Wang LL, Zhang JX, He CH, Shao S, Zhang TT, Xing JG, Liu R (2018) Total flavonoid extract from Dracoephalum moldavica L. attenuates \u03b2-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways. Life Sci 193:214\u2013225. https:\/\/doi.org\/10.1016\/j.lfs.2017.10.041","journal-title":"Life Sci"},{"issue":"3","key":"2914_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5114\/fn.2014.45568","volume":"52","author":"D Makarewicz","year":"2014","unstructured":"Makarewicz D, Sulejczak D, Duszczyk M, Ma\u0142ek M, S\u0142omka M, Lazarewicz JW (2014) Delayed preconditioning with NMDA receptor antagonists in a rat model of perinatal asphyxia. Folia Neuropathol 52(3):270\u2013284. https:\/\/doi.org\/10.5114\/fn.2014.45568","journal-title":"Folia Neuropathol"},{"issue":"7000","key":"2914_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson MP (2004) Pathways towards and away from Alzheimer\u2019s disease. Nature 430(7000):631\u2013639. https:\/\/doi.org\/10.1038\/nature02621","journal-title":"Nature"},{"issue":"10","key":"2914_CR36","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/14656566.2019.1612365","volume":"20","author":"T M\u00fcller","year":"2019","unstructured":"M\u00fcller T, Kuhn W, M\u00f6hr JD (2019) Evaluating ADS5102 (amantadine) for the treatment of Parkinson\u2019s disease patients with dyskinesia. Expert Opin Pharmacother 20(10):1181\u20131187. https:\/\/doi.org\/10.1080\/14656566.2019.1612365","journal-title":"Expert Opin Pharmacother"},{"issue":"5254","key":"2914_CR37","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1126\/science.271.5254.1406","volume":"271","author":"G Multhaup","year":"1996","unstructured":"Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, Beyreuther K (1996) The amyloid precursor protein of Alzheimer\u2019s disease in the reduction of copper (II) to copper (I). Science 271(5254):1406\u20131409. https:\/\/doi.org\/10.1126\/science.271.5254.1406","journal-title":"Science"},{"key":"2914_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","volume":"11","author":"X Pan","year":"2019","unstructured":"Pan X, Kaminga AC, Wen S, Wu X, Acheampong K, Liu A (2019) Dopamine and dopamine receptors in Alzheimer\u2019s disease: a systematic review and network meta-analysis. Front Aging Neurosci 11:175. https:\/\/doi.org\/10.3389\/fnagi.2019.00175","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"2914_CR39","doi-asserted-by":"publisher","first-page":"C1399","DOI":"10.1152\/ajpcell.00386.2005","volume":"290","author":"H Parfenova","year":"2006","unstructured":"Parfenova H, Basuroy S, Bhattacharya S, Tcheranova D, Qu Y, Regan RF, Leffler CW (2006) Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection. Am J Physiol-Cell Physiol 290(5):C1399\u2013C1410. https:\/\/doi.org\/10.1152\/ajpcell.00386.2005","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"6","key":"2914_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, St\u00f6ffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 53(6):699\u2013723. https:\/\/doi.org\/10.1016\/j.neuropharm.2007.07.013","journal-title":"Neuropharmacology"},{"issue":"30","key":"2914_CR41","doi-asserted-by":"publisher","first-page":"19784","DOI":"10.1039\/C8CP03716G","volume":"20","author":"GL Perlovich","year":"2018","unstructured":"Perlovich GL, Volkova TV (2018) Sublimation thermodynamics aspects of adamantane and memantine derivatives of sulfonamide molecular crystals. Phys Chem Chem Phys 20(30):19784\u201319791. https:\/\/doi.org\/10.1039\/C8CP03716G","journal-title":"Phys Chem Chem Phys"},{"issue":"4","key":"2914_CR42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1039\/C4CE02076F","volume":"17","author":"GL Perlovich","year":"2015","unstructured":"Perlovich GL, Ryzhakov AM, Tkachev VV, Proshin AN (2015) Adamantane derivatives of sulfonamide molecular crystals: structure, sublimation thermodynamic characteristics, molecular packing, and hydrogen bond networks. CrystEngComm 17(4):753\u2013763. https:\/\/doi.org\/10.1039\/C4CE02076F","journal-title":"CrystEngComm"},{"issue":"13","key":"2914_CR43","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.1039\/C6CP00379F","volume":"18","author":"GL Perlovich","year":"2016","unstructured":"Perlovich GL, Volkova TV, Sharapova AV, Kazachenko VP, Strakhova NN, Proshin AN (2016) Adamantane derivatives of sulfonamides: sublimation, solubility, solvation and transfer processes in biologically relevant solvents. Phys Chem Chem Phys 18(13):9281\u20139294. https:\/\/doi.org\/10.1039\/C6CP00379F","journal-title":"Phys Chem Chem Phys"},{"issue":"11","key":"2914_CR44","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1021\/ed078p1499","volume":"78","author":"HN Po","year":"2001","unstructured":"Po HN, Senozan NM (2001) The Henderson-Hasselbalch equation: its history and limitations. J Chem Educ 78(11):1499\u20131503. https:\/\/doi.org\/10.1021\/ed078p1499","journal-title":"J Chem Educ"},{"key":"2914_CR45","unstructured":"Raevsky OA, Grigor\u2019ev VJ, Trepalin SV (1999) HYBOT program package. Registration by Russian State Patent Agency (990090)"},{"issue":"2","key":"2914_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","volume":"5","author":"MA Ramakrishnan","year":"2016","unstructured":"Ramakrishnan MA (2016) Determination of 50% endpoint titer using a simple formula. World J Virol 5(2):85. https:\/\/doi.org\/10.5501\/wjv.v5.i2.85","journal-title":"World J Virol"},{"issue":"3","key":"2914_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","volume":"9","author":"MA Rogawski","year":"2003","unstructured":"Rogawski MA, Wenk GL (2003) The neuropharmacological basis for the use of memantine in the treatment of Alzheimer\u2019s disease. CNS Drug Rev 9(3):275\u2013308. https:\/\/doi.org\/10.1111\/j.1527-3458.2003.tb00254.x","journal-title":"CNS Drug Rev"},{"issue":"12","key":"2914_CR48","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.5897\/AJPP2019.5070","volume":"5","author":"SA Saganuwan","year":"2011","unstructured":"Saganuwan SA (2011) A modified arithmetical method of Reed and Muench for determination of a relatively ideal median lethal dose (LD50). Afr J Pharmacy Pharmacol 5(12):1543\u20131546. https:\/\/doi.org\/10.5897\/AJPP2019.5070","journal-title":"Afr J Pharmacy Pharmacol"},{"key":"2914_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/bs.apcsb.2017.02.001","volume":"108","author":"Y Sawikr","year":"2017","unstructured":"Sawikr Y, Yarla NS, Peluso I, Kamal MA, Aliev G, Bishayee A (2017) Neuroinflammation in Alzheimer\u2019s disease: the preventive and therapeutic potential of polyphenolic nutraceuticals. Adv Protein Chem Struct Biol 108:33\u201357. https:\/\/doi.org\/10.1016\/bs.apcsb.2017.02.001","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"1","key":"2914_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0014-2999(70)90194-9","volume":"13","author":"B Scatton","year":"1970","unstructured":"Scatton B, Cheramy A, Besson MJ, Glowinski J (1970) Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. Eur J Pharmacol 13(1):131\u2013133","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2914_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.mehy.2005.03.011","volume":"65","author":"HP Schmitt","year":"2005","unstructured":"Schmitt HP (2005) On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease. Med Hypotheses 65(2):259\u2013265. https:\/\/doi.org\/10.1016\/j.mehy.2005.03.011","journal-title":"Med Hypotheses"},{"issue":"6","key":"2914_CR52","doi-asserted-by":"publisher","first-page":"H2592","DOI":"10.1152\/ajpheart.00520.2003","volume":"285","author":"CD Sharp","year":"2003","unstructured":"Sharp CD, Hines I, Houghton J, Warren A, Jackson TH, Jawahar A, Nanda A, Elrod JW, Long A, Chi A, Minagar A, Alexander JS (2003) Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am J Physiol-Heart Circulatory Physiol 285(6):H2592\u2013H2598. https:\/\/doi.org\/10.1152\/ajpheart.00520.2003","journal-title":"Am J Physiol-Heart Circulatory Physiol"},{"issue":"1","key":"2914_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11094-012-0723-2","volume":"46","author":"VA Shibnev","year":"2012","unstructured":"Shibnev VA, Garaev TM, Finogenova MP, Shevchenko ES, Burtseva EI (2012) Some pathways to overcoming drug resistance of influenza a virus to adamantane derivatives. Pharm Chem J 46(1):1\u20135. https:\/\/doi.org\/10.1007\/s11094-012-0723-2","journal-title":"Pharm Chem J"},{"issue":"8","key":"2914_CR54","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","volume":"1768","author":"DG Smith","year":"2007","unstructured":"Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer\u2019s disease amyloid \u03b2 peptide. Biochim Biophys Acta BBA-Biomembranes 1768(8):1976\u20131990. https:\/\/doi.org\/10.1016\/j.bbamem.2007.02.002","journal-title":"Biochim Biophys Acta BBA-Biomembranes"},{"issue":"29","key":"2914_CR55","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.2174\/0929867323666160525114026","volume":"23","author":"K Spilovska","year":"2016","unstructured":"Spilovska K, Zemek F, Korabecny J, Nepovimova E, Soukupa O, Windischd M, Kuca K (2016) Adamantane\u2013a lead structure for drugs in clinical practice. Curr Med Chem 23(29):3245\u20133266. https:\/\/doi.org\/10.2174\/0929867323666160525114026","journal-title":"Curr Med Chem"},{"issue":"12","key":"2914_CR56","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.18632\/aging.100413","volume":"3","author":"R Tacutu","year":"2011","unstructured":"Tacutu R, Budovsky A, Yanai H, Fraifeld VE (2011) Molecular links between cellular senescence, longevity and age-related diseases\u2013a systems biology perspective. Aging Albany NY 3(12):1178\u20131191. https:\/\/doi.org\/10.18632\/aging.100413","journal-title":"Aging Albany NY"},{"issue":"4","key":"2914_CR57","doi-asserted-by":"publisher","first-page":"e60309","DOI":"10.1371\/journal.pone.0060309","volume":"8","author":"KK Tai","year":"2013","unstructured":"Tai KK, Truong DD (2013) Amiloride but not memantine reduces neurodegeneration, seizures and myoclonic jerks in rats with cardiac arrest-induced global cerebral hypoxia and reperfusion. PLoS ONE 8(4):e60309. https:\/\/doi.org\/10.1371\/journal.pone.0060309","journal-title":"PLoS ONE"},{"issue":"1","key":"2914_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44\u201384. https:\/\/doi.org\/10.1016\/j.biocel.2006.07.001","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"2914_CR59","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s12640-018-9988-x","volume":"35","author":"KM Varier","year":"2019","unstructured":"Varier KM, Sumathi T (2019) Hinokitiol offers neuroprotection against 6-OHDA-induced toxicity in SH-SY5Y neuroblastoma cells by downregulating mRNA expression of MAO\/\u03b1-Synuclein\/LRRK2\/PARK7\/PINK1\/PTEN Genes. Neurotox Res 35(4):945\u2013954. https:\/\/doi.org\/10.1007\/s12640-018-9988-x","journal-title":"Neurotox Res"},{"issue":"25","key":"2914_CR60","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1039\/C8CE00426A","volume":"20","author":"AP Voronin","year":"2018","unstructured":"Voronin AP, Volkova TV, Ilyukhin AB, Trofimova TP, Perlovich GL (2018) Structural and energetic aspects of adamantane and memantine derivatives of sulfonamide molecular crystals: experimental and theoretical characterisation. CrystEngComm 20(25):3476\u20133489. https:\/\/doi.org\/10.1039\/C8CE00426A","journal-title":"CrystEngComm"},{"key":"2914_CR61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neubiorev.2013.11.008","volume":"38","author":"F Zeid\u00e1n-Chuli\u00e1","year":"2014","unstructured":"Zeid\u00e1n-Chuli\u00e1 F, Salmina AB, Malinovskaya NA, Noda M, Verkhratsky A, Moreira JCF (2014) The glial perspective of autism spectrum disorders. Neurosci Biobehav Rev 38:160\u2013172. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.11.008","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"2914_CR62","doi-asserted-by":"publisher","first-page":"22795","DOI":"10.3390\/ijms160922795","volume":"16","author":"J Zhao","year":"2015","unstructured":"Zhao J, Peng L, Zheng W, Wang R, Zhang L, Yang J, Chen H (2015) Chemically bonding of amantadine with gardenamide a enhances the neuroprotective effects against corticosterone-induced insults in PC12 cells. Int J Mol Sci 16(9):22795\u201322810. https:\/\/doi.org\/10.3390\/ijms160922795","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2914_CR63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/ph7020113","volume":"7","author":"H Zheng","year":"2014","unstructured":"Zheng H, Fridkin M, Youdim M (2014) From single target to multitarget\/network therapeutics in Alzheimer\u2019s therapy. Pharmaceuticals 7(2):113\u2013135. https:\/\/doi.org\/10.3390\/ph7020113","journal-title":"Pharmaceuticals"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-020-02914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-020-02914-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-020-02914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T08:38:41Z","timestamp":1608021521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-020-02914-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,15]]},"references-count":63,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2914"],"URL":"https:\/\/doi.org\/10.1007\/s00726-020-02914-4","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,15]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors listed have contributed to conception, design, gathering, analysis, or interpretation of data, and have contributed to the writing and intellectual content of the article. All the authors gave informed consent to the submission of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}